Your session is about to expire
← Back to Search
Electrical Stimulation + Occupational Therapy for Stroke Recovery
N/A
Waitlist Available
Led By Jayme Knutson, PhD
Research Sponsored by MetroHealth Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Skin intact on the hemiparetic arm
Full voluntary opening/closing of the contralateral (less affected) hand
Must not have
Diagnosis (apart from stroke) that substantially affects paretic arm and hand function
Severe shoulder or hand pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 to 12 weeks, 0 to 36 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing three different therapies to see which is better at helping people recover hand function after a stroke.
Who is the study for?
This trial is for adults who've had their first stroke 6-24 months ago, leading to hand weakness but can still open their other hand fully. They should be able to follow instructions and have no severe pain when using a finger stimulator. Excluded are those with other neurological issues, uncontrolled seizures, certain heart conditions, pregnancy, or visual/hearing impairments that would affect participation.
What is being tested?
The study compares three therapies aimed at improving hand function after a stroke: an electrical stimulator designed to help move fingers and thumb; occupational therapy; and possibly a combination of both. It seeks to find out which method might be most effective in aiding recovery.
What are the potential side effects?
Potential side effects may include discomfort or skin irritation from the electrical stimulator's use on the arm. Occupational therapy generally has minimal risks but could cause fatigue or muscle soreness due to repetitive exercises.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
The skin on my weaker arm is not broken or damaged.
Select...
I can fully open and close my less affected hand.
Select...
My hand mobility score is between 1 and 11 on a specific test.
Select...
I can move my shoulder and elbow well enough to use my hand for table-top tasks.
Select...
Stimulating my weak hand's muscles can open it without pain.
Select...
My arm is weak but I can move my fingers partially.
Select...
I can understand and follow three-step instructions.
Select...
I can remember at least 2 out of 3 items after half an hour.
Select...
I am not currently undergoing occupational therapy.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a condition that significantly impacts the function of my affected arm and hand, not caused by a stroke.
Select...
I have severe pain in my shoulder or hand.
Select...
I have had serious heart rhythm problems that affected my blood pressure.
Select...
I have a neurological condition like MS, Parkinson's, or a spinal cord injury.
Select...
I cannot feel my forearm or hand.
Select...
I have had a stroke in the brainstem.
Select...
I have seizures that are not controlled by medication.
Select...
I cannot move my wrist or fingers on one side without help.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0 to 12 weeks, 0 to 36 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 to 12 weeks, 0 to 36 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Box and Blocks Test (BBT) change
Secondary study objectives
Stroke Upper Limb Capacity Scale (SULCS) change
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: CCFESExperimental Treatment2 Interventions
Contralaterally Controlled Functional Electrical Stimulation (CCFES) uses an electrical stimulator and surface electrodes placed over the paretic finger and thumb extensors to deliver stimulation with an intensity that is proportional to the degree of opening of the contralateral unimpaired hand wearing an instrumented glove. Thus, volitional opening of the nonparetic hand produces stimulated opening of the paretic hand. During the lab visits, participants in the CCFES group will use CCFES to assist hand opening during occupational therapy task practice. During their home sessions, participants in the CCFES group will use CCFES to perform hand opening exercise.
Group II: cNMESActive Control2 Interventions
Cyclic Neuromuscular Electrical Stimulation (cNMES) uses an electrical stimulator and surface electrodes over the paretic finger and thumb extensors to deliver electrical stimulation to open the weak hand. The stimulation automatically turns on and off causing the weak hand to open repetitively for several seconds at a time. During the lab visits, participants in the cNMES group will receive occupational therapy task practice. During their home sessions, participants in the cNMES group will use cNMES to perform hand opening exercise.
Group III: Task Oriented TherapyActive Control1 Intervention
Task Oriented Therapy (TOT) focuses on practicing using the weak hand to practice activities of daily living tasks. During the clinic visits, participants in the TOT group will receive occupational therapy task practice. During their home sessions, participants in the TOT group will practice using their hand to complete a list of tasks given to them by the therapist to ensure that the participant receives a high dose of task practice.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Electrical Stimulator
2013
N/A
~70
Occupational Therapy
2011
Completed Phase 3
~1200
Find a Location
Who is running the clinical trial?
MetroHealth Medical CenterLead Sponsor
118 Previous Clinical Trials
21,568 Total Patients Enrolled
16 Trials studying Stroke
827 Patients Enrolled for Stroke
Kessler FoundationOTHER
181 Previous Clinical Trials
10,947 Total Patients Enrolled
27 Trials studying Stroke
2,360 Patients Enrolled for Stroke
National Institutes of Health (NIH)NIH
2,810 Previous Clinical Trials
8,159,500 Total Patients Enrolled
43 Trials studying Stroke
8,339 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had a stroke between 6 and 24 months ago.The skin on my weaker arm is not broken or damaged.I have a condition that significantly impacts the function of my affected arm and hand, not caused by a stroke.I have severe pain in my shoulder or hand.You cannot see the display of the device clearly.You can hear and respond to signals from the device.I have had serious heart rhythm problems that affected my blood pressure.I haven't had botulinum toxin injections in my arm muscles in the last 3 months.I can fully open and close my less affected hand.I have a neurological condition like MS, Parkinson's, or a spinal cord injury.My hand mobility score is between 1 and 11 on a specific test.I can move my shoulder and elbow well enough to use my hand for table-top tasks.Stimulating my weak hand's muscles can open it without pain.My arm is weak but I can move my fingers partially.I can understand and follow three-step instructions.I can remember at least 2 out of 3 items after half an hour.You have difficulty paying attention to one side of your body.I am not currently undergoing occupational therapy.I cannot feel my forearm or hand.I have had a stroke in the brainstem.I have seizures that are not controlled by medication.You have a pacemaker or other implanted electronic devices.I cannot move my wrist or fingers on one side without help.
Research Study Groups:
This trial has the following groups:- Group 1: cNMES
- Group 2: Task Oriented Therapy
- Group 3: CCFES
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger